Showing results (591-600 of 9,918) with videos related to
Sort By:
Pageof 992
Bone Marrow Transplantation|June 26, 1999
Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemiaA P Jillella, R Doria, K Khan, et al.Bone Marrow Transplantation|June 26, 1999
High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deathsK S Baker, M G Roncarolo, C Peters, et al.Bone Marrow Transplantation|June 26, 1999
Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's diseaseD E Reece, T J Nevill, A Sayegh, et al.Bone Marrow Transplantation|June 26, 1999
Pre-treatment of transplant bone marrow cells with hydrocortisone and cyclosporin A alleviates graft-versus-host reaction in a murine allogeneic host-donor combinationD Grcević, D Batinić, J L Ascensao, et al.Bone Marrow Transplantation|June 26, 1999
Opportunistic CNS infection after bone marrow transplantationM Maschke, U Dietrich, M Prumbaum, et al.Bone Marrow Transplantation|June 26, 1999
Multicentre European study comparing selection techniques for the isolation of CD34+ cellsE A de Wynter, D Ryder, F Lanza, et al.Bone Marrow Transplantation|June 26, 1999
Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantationW Y Au, A K Lie, C K Lee, et al.Bone Marrow Transplantation|July 22, 1999
Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institutionN Ketterer, A Sonet, C Dumontet, et al.Bone Marrow Transplantation|July 22, 1999
Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantationY Nawa, K Takenaka, K Shinagawa, et al.Bone Marrow Transplantation|May 21, 1999
Economic considerations in the use of peripheral blood progenitor cells to support high-dose chemotherapyJ A GlaspyPageof 992